PAHC
Phibro Animal Health Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -10.0% ·
share flow +8.9% ·
net new positions -11.1%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | -16 | 15.41M | $484.55M | +5 | −21 |
| Q1 2026 | 95 | +6 | 14.51M | $800.97M | +11 | −5 |
| Q4 2025 | 89 | +1 | 14.47M | $540.64M | +1 | — |
| Q3 2025 | 17 | +1 | 9.22M | $372.92M | +1 | — |
| Q2 2025 | 13 | +1 | 8.13M | $207.65M | +2 | −1 |
| Q1 2025 | 9 | 0 | 3.02M | $64.46M | +1 | −1 |
| Q4 2024 | 9 | -1 | 3.00M | $62.94M | — | −1 |
| Q3 2024 | 9 | -1 | 1.81M | $40.65M | — | −1 |
| Q2 2024 | 10 | — | 1.66M | $27.80M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 547.20K | +3.9% | $12.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 507.47K | +5.7% | $11.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 507.47K | +5.7% | $11.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 256.27K | +39.9% | $5.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 256.27K | +39.9% | $5.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 256.27K | +39.9% | $5.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 237.49K | +56.4% | $5.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 88.34K | -24.7% | $1.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 88.34K | -24.7% | $1.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 76.90K | +21.9% | $1.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 62.39K | +107.3% | $1.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 16.10K | +1.1% | $363,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 12.90K | -43.2% | $290,621 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $1.11M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 255 holders, 20.06M shares, $1.03B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
48.2% of class · View original SEC filing ↗